drugset
Drugs / Human Mesenchymal Stromal Cells
last change Jun 2024 re-read 3 minutes ago

Human Mesenchymal Stromal Cells

also known as hMSCs

Cell therapy

Developed for
adult acute respiratory distress syndrome
Investigated by
Harborview Injury Prevention and Research Center · Michael A. Matthay · Oregon Health and Science University · The University of Texas Health Science Center, Houston · United States Department of Defense · University of Minnesota
+1 more · Vanderbilt University Medical Center

Trials 1

today NCT03818854 · Ph 2
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03818854 Nov 2019 → Mar 2024 adult acute respiratory distress syndrome Michael A. Matthay Completed Missed primary

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Mesenchymal Stromal Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT03818854 ↗
Known as hMSCs “Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion” NCT03818854 ↗
Modality Cell therapy “Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion” NCT03818854 ↗
Route Intravenous “administered intravenously” NCT03818854 ↗